07/22/2014 - 2:11pm
Report: Lupin, other firms may bid for GSK's portfolio of 'mature' drugs

Lupin, along with certain U.S. drugmakers and private equity funds, mght be making plans to bid for a selection of older drugs from GlaxoSmithKline, according to Reuters, which cited sources familiar with the dealings.

07/22/2014 - 1:41pm
FDA gives tentative approval to Teva's abacavir sulfate, lamivudine tabs

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.

07/22/2014 - 1:24pm
Walgreens opens pharmacy at Children’s National Health System

Walgreens announced the official opening of a new pharmacy at Children's National Health System.

07/22/2014 - 1:07pm
Walgreens announces new Balance Rewards for healthy choices

Walgreens on Tuesday announced the new Balance Rewards for healthy choices initiatives, which is aimed at helping participants modify behavior risk factors associated with the nation's most pressing public health issues.

07/21/2014 - 4:01pm
Illinois expands medical marijuana for epileptics, minors

Illinois Gov. Pat Quinn signed a bill Monday that opens up medical marijuana to treat symptoms of epilepsy in adults and children.

07/21/2014 - 2:44pm
Office of Generic Drugs updates key leadership positions

The Food and Drug Administration’s Center for Drug Evaluation and Research is providing an update to key leadership positions within the Office of Generic Drugs, the agency announced.

07/21/2014 - 2:32pm
New prescription counter double-counts, stores data

The new KL1Plus double counts the tablets it dispenses and can then store the count data for up to 10 years.

07/21/2014 - 12:33pm
AbbVie reaches a deal with Shire

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

07/21/2014 - 11:27am
JAMA commentary: Value of specialty medications not measured on cost alone

Commentary published online Monday addresses the controversy surrounding the high costs of new Hepatitis C virus treatments and implications for the growing specialty pharmacy market. 

 

07/21/2014 - 10:48am
Innocutis introduces Sitavig tabs

Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.